Giles Turner, from Brighton, is one of the men who could benefit from the drug Men with aggressive prostate cancer should be given a drug that halves their risk of death, experts have urged the NHS.

Screening men for prostate cancer would save thousands of lives by slashing their risk of dying from the disease by 13 per cent, a major study reveals. Testing led to a ‘sustained reduction’ in deaths ...

Of 16,732 patients with metastatic prostate cancer who died after being diagnosed between 2000 and 2016, nearly 17 percent died from other causes, according to a study published Aug. 5 in JAMA Network ...

The issues affecting you. Revealed. Explained. Discussed. Now on WGAL 8 InFocus. Hello, I'm Susan Shapiro. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime. The American ...

SALT LAKE CITY — Former President Joe Biden's prostate cancer diagnosis has brought an old conversation to the forefront of headlines, and it's one that men in Utah need to hear, because right now, ...

While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...

Erleada shows consistent 24-month overall survival in real-world settings and the TITAN trial for metastatic castration-sensitive prostate cancer. Erleada reduces the risk of death by 23% compared to ...

Scott Adams, the cartoonist behind the popular strip "Dilbert," is sharing a critical update on his battle with cancer.

A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history ...

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.